Crinipellin B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Bioactive by-products |
Catalog number | BBF-01074 |
CAS | 97294-61-6 |
Molecular Weight | 330.42 |
Molecular Formula | C20H26O4 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Crinipellis stipitaria. It has anti-gram-positive bacteria and Aldrin ascites carcinoma activity.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | (1aS,3aR,4aS,7R,7aR,9R,9aR,9bR)-9-hydroxy-7-isopropyl-7a,9a-dimethyl-3-methyleneoctahydro-3H,8H-pentaleno[6a',1':5,6]pentaleno[1,6a-b]oxirene-2,8(1aH)-dione |
IUPAC Name | (1S,3R,6S,8R,9R,10R,12R,13R)-10-hydroxy-9,12-dimethyl-4-methylidene-13-propan-2-yl-7-oxapentacyclo[7.6.0.01,12.03,8.06,8]pentadecane-5,11-dione |
Canonical SMILES | CC(C)C1CCC23C1(C(=O)C(C2(C45C(C3)C(=C)C(=O)C4O5)C)O)C |
InChI | InChI=1S/C20H26O4/c1-9(2)11-6-7-19-8-12-10(3)13(21)16-20(12,24-16)18(19,5)15(23)14(22)17(11,19)4/h9,11-12,15-16,23H,3,6-8H2,1-2,4-5H3/t11-,12-,15+,16-,17+,18+,19-,20+/m1/s1 |
InChI Key | PBZBBNIYZKWVGM-NPWZTIOKSA-N |
Appearance | Crystal |
Antibiotic Activity Spectrum | Gram-positive bacteria; Neoplastics (Tumor) |
Melting Point | 150-151 °C |
Solubility | Soluble in Chloroform |
BBF-03709 | Nemadectin | Inquiry |
BBF-05818 | Docosahexaenoic acid | Inquiry |
BBF-05853 | Palbociclib | Inquiry |
BBF-00664 | Alternariol | Inquiry |
BBF-02576 | Pneumocandin B0 | Inquiry |
BBF-03428 | Tubermycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
